XML 33 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Note 17 - Warrant Liabilities
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Warrants Disclosure [Text Block]
17.
Warrant liabilities
 
The Company consummated a registered director offering
in
January 2018 (
the
“2018
Financing”), as part of the transaction
, the Company
issued to the investors and the placement agent warrants to purchase up to
645,000
and
129,000
shares of the Company’s common stock at an exercise price of
$6.60
per share, respectively.
The Company accounted for these warrants as derivative liabilities. As a result, these warrants were remeasured at fair value as of each reporting date with changes in fair value be recorded in earnings in each reporting period.
 
Fair value of the warrants
 
The Company used Binomial model to determine the fair value of the Warrants based on the assumptions summarized as below:
 
    Investors warrants   Placement agent warrants
      As of
December 31, 2019
      As of
March 31, 2020
      As of
December 31, 2019
      As of
March 31, 2020
 
                 
Stock price   $
1.17
    $
0.95
    $
1.17
    $
0.95
 
Years to maturity    
0.55
     
0.30
     
1.05
     
0.80
 
Risk-free interest rate    
1.58
%    
0.10
%    
1.57
%    
0.13
%
Dividend yield    
-
     
-
     
-
     
-
 
Expected volatility    
60
%    
99
%    
80
%    
78
%
Exercise Price *   $
1.4927
    $
1.4927
    $
1.4927
    $
1.4927
 
                                 
Fair value of the warrant   $
0.11
    $
0.07
    $
0.28
    $
0.12
 
                                 
Warrant Liabilities (US$’000)   $
71
    $
45
    $
36
    $
16
 
 
 
    Investors warrants   Placement agent warrants
      As of
December 31, 2018
      As of
March 31, 2019
      As of
December 31, 2018
      As of
March 31, 2019
 
                 
Stock price   $
1.34
    $
1.95
    $
1.34
    $
1.95
 
Years to maturity    
1.55
     
1.30
     
2.05
     
1.80
 
Risk-free interest rate    
2.50
%    
2.27
%    
2.50
%    
2.27
%
Dividend yield    
-
     
-
     
-
     
-
 
Expected volatility    
199
%    
216
%    
176
%    
187
%
Exercise Price *   $
6.60
    $
6.60
    $
6.60
    $
6.60
 
                                 
Fair value of the warrant   $
0.78
    $
1.23
    $
0.80
    $
1.26
 
                                 
Warrant Liabilities (US$’000)   $
503
    $
793
    $
103
    $
163
 
 
* On
September 25, 2019,
as a result of the close on the
first
half of a private placement with a selected group of investors, the exercise price of the warrants issued in the
2018
Financing that contain the “full ratchet” price protection in the event of subsequent issuances below the applicable exercise price (the “Down round feature”) was adjusted to
$1.4927.
 
Changes in fair value of warrant liabilities
Three Months Ended
March 31, 2020 (
Unaudited)
 
   
 
As of
March 31, 2020
 
 
 
As of
December 31, 2019
 
 
 
Change in Fair Value
(gain)/loss
 
   
US$’000
 
US$’000
 
US$’000
Fair value of the Warrants:                        
Investor warrants    
45
 
   
71
 
   
(26
)
Placement agent warrants    
16
 
   
36
 
   
(20
)
Warrant liabilities    
61
 
   
107
 
   
(46
)
 
Three Months Ended
March 31, 2019 (
Unaudited)
 
   
 
As of
March 31, 2019
 
 
 
As of
December 31, 2018
 
 
 
Change in Fair Value
(gain)/loss
 
   
US$’000
 
US$’000
 
US$’000
Fair value of the Warrants:                        
Investor warrants    
793
 
   
503
 
   
290
 
Placement agent warrants    
163
 
   
103
 
   
60
 
Warrant liabilities    
956
 
   
606
 
   
350
 
 
Warrants issued and outstanding as of
March 31, 2020
and their movements during the
three
months then ended are as follows:
 
    Warrant Outstanding   Warrant Exercisable
      Number of underlying shares       Weighted
Average
Remaining
Contractual
Life (Years)
    Weighted
Average
Exercise
Price
    Number of underlying shares       Weighted
Average
Remaining
Contractual
Life (Years)
    Weighted
Average
Exercise
Price
                         
Balance, January 1, 2020    
774,000
     
0.63
    $
1.4927
     
774,000
     
0.63
    $
1.4927
 
Granted/Vested    
-
     
 
     
 
     
-
     
 
     
 
 
Forfeited    
-
     
 
     
 
     
-
     
 
     
 
 
Exercised    
-
     
 
     
 
     
-
     
 
     
 
 
Balance, March 31, 2020 (Unaudited)    
774,000
     
0.38
    $
1.4927
     
774,000
     
0.38
    $
1.4927